Veradigm | MDRX - Операционный доход





Операционный доход Изменить Дата
Alcidion AUD 2.2M 1.76M 2025-12
Ambu A/S DKK 173M 9M 2026-03
Amplifon EUR 48.08M 23.79M 2025-12
Cardinal Health USD 861M 98M 2026-03
Centene USD 1.86B 3.09B 2026-03
Charles River Laboratories USD 119.9M 44.08M 2026-03
Cigna USD 2.76B 204M 2026-03
Coloplast 1.85B 102M 2025-12
Computer Programs Systems USD -119.41M 121.35M 2025-12
Convatec Group USD 175.7M 101.1M 2024-12
CVS Health USD 4.68B 2.57B 2026-03
Diasorin EUR 56M 8.57M 2026-03
Elevance Health USD -5.81B 6.39B 2026-03
General Electric Aerospace USD 2.32B 549M 2026-03
Gulf Medical Proj AED 30.8M 8.97M 2025-12
Humana USD 1.75B 2.56B 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
Laboratory Of America USD 410.1M 28.1M 2026-03
Maximus USD 148.49M 2.28M 2026-03
McKesson USD 1.84B 181M 2026-03
Med Life RON 40.09M 1.45M 2025-09
Molina Healthcare USD 176M 329M 2026-03
Omnicell USD 17.04M 15.85M 2026-03
Oriola-kd EUR 5.4M 1.2M 2025-12
Owens Minor USD 814K 28.08M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Rede D'or Sao Luiz BRL 2.91B 350.85M 2026-03
Siemens Healthineers EUR 726M 49M 2026-03
Sonova Holding CHF 296.8M 156.9M 2025-12
Supermax Corporation Bhd MYR -63.56M 79.6M 2025-12
UnitedHealth USD 9.04B 5.78B 2026-03
Veeva Systems USD 245.88M 5.02M 2025-12
Veradigm USD -45.47M 70.47M 2022-12
Xerox USD 30M 48M 2025-06